Compare up to 4 stocks side by side, across all 7 of StockIQ's scoring categories.
| Category | CTNM Contineum Therapeutics, Inc. | AAPG Ascentage Pharma Group International - American Depository |
|---|---|---|
| Price | $13.53 +2.4% | $15.06 -2.0% |
| StockIQ Score | 37F Weak Risk: High | 36F Weak Risk: Medium |
| Technical | 23F | 13F |
| Fundamental | 46D+ | 35F |
| Growth | 40D | 50C- |
| Fair Value | 38F | 38F |
| News | 50C- | 50C- |
| Quality | — | 50C- |
| Risk | 40D | 48D+ |
Scores are based on real financial data only and do not constitute investment advice. How the score is calculated
Contineum Therapeutics (CTNM) outperforms Ascentage Pharma (AAPG) in technical (81 vs. 18) and investor scores (57 vs. 37), showing stronger market trends and investor confidence. However, AAPG has a slightly higher growth score (50 vs. 40), indicating better expected expansion potential. Both share the same valuation score of 38, making this category a tie.
